Minor
Established
설명
Combined use of carvedilol and lisinopril in heart failure is guideline-recommended but carries additive hypotensive risk, particularly with initiation or dose uptitration.
기전
Carvedilol provides alpha-1 and non-selective beta blockade; lisinopril reduces angiotensin II–mediated vasoconstriction. Additive vasodilation and negative inotropy can cause hypotension.
임상적 중요성
The combination is standard-of-care in HFrEF; benefits include mortality reduction; the primary risk is hypotension, dizziness, and fatigue, especially early in therapy.
관리 방법
Initiate at lowest doses; uptitrate each agent separately; monitor blood pressure and renal function throughout titration.